Biological and Pharmacological Activity of Plant Natural Compounds II
The Special issue "Biological and Pharmacological Activity of Plant Natural Compounds II" is continuing the intriguing research on the use of natural plant products. The second edition follows the aim of the first one.
Збережено в:
| Інші автори: | , |
|---|---|
| Формат: | Електронний ресурс Частина з книги |
| Мова: | Англійська |
| Опубліковано: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2022
|
| Предмети: | |
| Онлайн доступ: | DOAB: download the publication DOAB: description of the publication |
| Теги: |
Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_81145 | ||
| 005 | 20220506 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20220506s2022 xx |||||o ||| 0|eng d | ||
| 020 | |a books978-3-0365-3505-0 | ||
| 020 | |a 9783036535067 | ||
| 020 | |a 9783036535050 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.3390/books978-3-0365-3505-0 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a M |2 bicssc | |
| 072 | 7 | |a MMG |2 bicssc | |
| 100 | 1 | |a Pezzani, Raffaele |4 edt | |
| 700 | 1 | |a Vitalini, Sara |4 edt | |
| 700 | 1 | |a Pezzani, Raffaele |4 oth | |
| 700 | 1 | |a Vitalini, Sara |4 oth | |
| 245 | 1 | 0 | |a Biological and Pharmacological Activity of Plant Natural Compounds II |
| 260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2022 | ||
| 300 | |a 1 electronic resource (338 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a The Special issue "Biological and Pharmacological Activity of Plant Natural Compounds II" is continuing the intriguing research on the use of natural plant products. The second edition follows the aim of the first one. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Medicine |2 bicssc | |
| 650 | 7 | |a Pharmacology |2 bicssc | |
| 653 | |a Bergenia species | ||
| 653 | |a botanical description | ||
| 653 | |a traditional uses | ||
| 653 | |a phytochemistry | ||
| 653 | |a pharmacology | ||
| 653 | |a anti-urolithiatic activity | ||
| 653 | |a bergenin | ||
| 653 | |a Flaxseed oil | ||
| 653 | |a linusorb B3 | ||
| 653 | |a anti-cancer | ||
| 653 | |a apoptosis | ||
| 653 | |a actin polymerization | ||
| 653 | |a Src | ||
| 653 | |a glioblastoma | ||
| 653 | |a chlorogenic acid | ||
| 653 | |a coffee | ||
| 653 | |a cyclooxygenase | ||
| 653 | |a espresso | ||
| 653 | |a instant coffee | ||
| 653 | |a platelet aggregation | ||
| 653 | |a Rubia tinctorum L. | ||
| 653 | |a antioxidants | ||
| 653 | |a polyphenols | ||
| 653 | |a ethylene glycol | ||
| 653 | |a urolithiasis | ||
| 653 | |a histophatology | ||
| 653 | |a Saccharomyces cerevisiae | ||
| 653 | |a β-glucan | ||
| 653 | |a antimicrobial and anticancer activities | ||
| 653 | |a detoxification ability | ||
| 653 | |a immunomodulatory effect | ||
| 653 | |a Aquilaria sinensis | ||
| 653 | |a pheophorbide A | ||
| 653 | |a MMP-2 | ||
| 653 | |a MMP-9 | ||
| 653 | |a HT-1080 | ||
| 653 | |a advanced glycation end product (AGE) | ||
| 653 | |a oxidative stress | ||
| 653 | |a epithelial to mesenchymal transition | ||
| 653 | |a AGE-inhibitor | ||
| 653 | |a swertiamarin | ||
| 653 | |a diabetic nephropathy | ||
| 653 | |a astragaloside IV | ||
| 653 | |a Astragalus membranaceus | ||
| 653 | |a huang qi | ||
| 653 | |a Astragali Radix | ||
| 653 | |a liver | ||
| 653 | |a liver regeneration | ||
| 653 | |a 70% partial hepatectomy | ||
| 653 | |a proliferation | ||
| 653 | |a rat | ||
| 653 | |a memory | ||
| 653 | |a object recognition | ||
| 653 | |a Ginkgo biloba | ||
| 653 | |a dorsal hippocampus formation | ||
| 653 | |a brain-derived neurotrophic factor | ||
| 653 | |a Diclofenac | ||
| 653 | |a γ-lactone | ||
| 653 | |a nano-emulsion | ||
| 653 | |a methylcellulose | ||
| 653 | |a Ostrich oil | ||
| 653 | |a Struthio camelus | ||
| 653 | |a Caenorhabditis elegans | ||
| 653 | |a leaf extract | ||
| 653 | |a neuroprotection | ||
| 653 | |a antioxidant activity | ||
| 653 | |a DAF-16 | ||
| 653 | |a Clerodendrum infortunatum | ||
| 653 | |a terpenoids | ||
| 653 | |a phenylpropanoids | ||
| 653 | |a antidiabetic | ||
| 653 | |a breast cancer | ||
| 653 | |a Combretum indicum L. | ||
| 653 | |a antidiabetic activity | ||
| 653 | |a histopathology | ||
| 653 | |a UPLC-QTOF/ESI-MS | ||
| 653 | |a network pharmacology | ||
| 653 | |a Biebersteinia heterostemon | ||
| 653 | |a galegine | ||
| 653 | |a hypotensive | ||
| 653 | |a toxicity | ||
| 653 | |a Sage | ||
| 653 | |a Salvia officinalis | ||
| 653 | |a cytotoxicity | ||
| 653 | |a hepatoprotection | ||
| 653 | |a MDA | ||
| 653 | |a TAOxC | ||
| 653 | |a MCF-7 | ||
| 653 | |a HeLA cells | ||
| 653 | |a HepG-2 cells | ||
| 653 | |a Peganum harmala | ||
| 653 | |a anti-inflammatory activity | ||
| 653 | |a antioxidant | ||
| 653 | |a LC-ESI-MS/MS | ||
| 653 | |a traditional medicine | ||
| 653 | |a rheumatoid arthritis | ||
| 653 | |a rosmanol | ||
| 653 | |a carnosol | ||
| 653 | |a Callicarpa longissima | ||
| 653 | |a TLR4/NF-κB/MAPK | ||
| 653 | |a synergistic effect | ||
| 653 | |a diabetes mellitus | ||
| 653 | |a anti-diabetic drugs | ||
| 653 | |a monoterpenes | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/5176 |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/81145 |7 0 |z DOAB: description of the publication |